Boudjelal Mohamed



Dr BOUDJELAL is Chairman of Medical Research Core Facilities & Platforms and Director of Drug Discovery Program at King Abdullah International Medical Research Center (KAIMRC), The Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia. Prior Joining KAIMRC, Dr. Boudjelal was a Group-Leader / Senior Investigator at GlaxoSmithKline, UK. Mohamed also held a position as an Associate Director for preclinical drug discovery in Incyte (Pfizer) pharmaceutical, USA, Scientist at Michigan University, USA and Institute of Genetic and Molecular and Cellular Biology, Strasbourg, France. Dr. Boudjelal holds a Ph.D. in Biochemistry and Molecular Biology from University of Leeds, UK, BSc in Biochemistry from University of Es Senia, Algeria, a degree in International Business and vocal education from University of California in San Diego. Dr. BOUDJELAL discovered number of therapeutics that were tested in clinical trials in human. Dr. Boudjelal is recipient of several awards for scientific research excellence. Dr. Boudjelal is the founder of Algerian Competences Association and The International Science Edit For the Developing World,